Altoran 40 Tablet 10s
(AZILSARTAN MEDOXOMIL)

Which class does Azilcad belong to?
Azilcad is classified as an angiotensin II receptor antagonist AIIRA a type of medication that belongs to a specific class of drugs In the human body angiotensin II is a naturally occurring substance that has the capability to constrict blood vessels resulting in an elevation of blood pressure However Azilcad works by inhibiting this effect promoting the relaxation of blood vessels and ultimately leading to a reduction in blood pressure levels By selectively blocking the action of angiotensin II on its receptors Azilcad exerts its therapeutic benefits This mechanism of action prevents the blood vessels from constricting ensuring that they remain expanded and allowing blood to flow more freely As a result the overall blood pressure is lowered contributing to the management of hypertension Azilcad offers a targeted approach in the treatment of high blood pressure as it specifically targets the angiotensin II receptors rather than interfering with other systems in the body This selective action contributes to its effectiveness and minimizes potential side effects In summary Azilcads role as an AIIRA involves counteracting the constricting effect of angiotensin II on blood vessels leading to their relaxation and a subsequent reduction in blood pressure This medication offers a valuable solution for individuals who require effective management of hypertension promoting overall cardiovascular health

Is Ibzil better than telmisartan?
Ibzil and telmisartan are both medications designed to lower blood pressure While Ibzil is a relatively recent addition to the market studies have shown it to be just as effective as telmisartan in reducing hypertension Furthermore Ibzil offers the advantage of having fewer side effects making it a safe and welltolerated option for patients This groundbreaking medicine has been proven to effectively regulate blood pressure levels providing individuals with a reliable solution to manage their condition With the growing concern over the adverse effects associated with certain medications Ibzils emergence offers hope to those seeking a treatment that not only effectively controls blood pressure but also minimizes the potential for unwanted side effects Patients can now have confidence in the effectiveness and safety of Ibzil as an alternative to telmisartan providing them with additional options for managing their blood pressure and ultimately improving their overall health and wellbeing